For the Inventor, By the Inventor

Enter assignee name

North Ryde, Australia

Biosceptre (aust) Pty Ltd

USPTO Granted Patents = 17

Trademarks = 2

Forward Citations = 51

Loading Chart...

Loading Chart...

10 inventors (with patents filed for the assignee):

Julian Alexander Barden (16 out of 32 patents)

Angus Gidley-Baird (10 out of 25 patents)

Philip Jones (4 out of 13 patents)

4. Neil Brewis (4 out of 5 patents)

5. Steven Grant (4 out of 20 patents)

6. Xiaojuan Gong (2 out of 3 patents)

7. Minoo Jalili Moghaddam (2 out of 14 patents)

8. Justin Taylor Coombs (1 out of 1 patent)

9. Simon Charles Barry (1 out of 1 patent)

10. Timothy John Sadlon (1 out of 1 patent)

17 patents: Sort by Forward Citations

1. 12129295 - Anti P2X7 receptor antibodies and fragments thereof (2024-10-29),

2. 12121539 - Chimeric antigen receptors and uses thereof (2024-10-22),

3. 12097265 - Cytotoxic particles for targeting P2X7 receptor (2024-09-24),

4. 11260131 - Cytotoxic particles for targeting P2X7 receptor (2022-03-01),

5. 10988532 - Anti P2Xreceptor antibodies and fragments thereof (2021-04-27),

6. 10597451 - Methods of treating cancer with a P2X7 peptide (2020-03-24),

7. 10543262 - Combination therapy utilizing P2X7 peptides (2020-01-28),

8. 10450380 - Polypeptide immunogen for generating an antibody to non-functional P2X7 receptor (2019-10-22),

9. 10245308 - Combination therapy utilizing P2X7 peptides (2019-04-02),

10. 10238716 - [object Object] (2019-03-26),

11. 10053508 - Anti P2X7 receptor antibodies and fragments thereof (2018-08-21),

12. 9944701 - Methods of treating cancer with antibodies that bind P2X7 receptors (2018-04-17),

13. 9688771 - [object Object] (2017-06-27),

14. 9663584 - Antibodies to non-functional P2X7 receptor (2017-05-30),

15. 9566318 - Combination therapy (2017-02-14),

BIOSCEPTRE (AUST) PTY LTD is a biotechnology company focused on the discovery and development of cancer drugs. With a strong emphasis on innovative science and cutting-edge technology, BIOSCEPTRE aims to revolutionize cancer treatment by targeting the nfP2X7 receptor, a promising biomarker for multiple cancer types. Their mission is to improve patient outcomes and quality of life by delivering safe and effective therapies. For more information, please visit their website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

17 Patents

#5 in North Ryde

#205 in Australia

#34,819 in the World

North Ryde, Australia

Biosceptre (aust) Pty Ltd

Forward Citations = 51

10 inventors:

Julian Alexander Barden (16 out of 32 patents)

Angus Gidley-Baird (10 out of 25 patents)

Philip Jones (4 out of 13 patents)

4. Neil Brewis (4 out of 5 patents)

5. Steven Grant (4 out of 20 patents)

Please report any incorrect information to support@idiyas.com

Loading…